Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial. Ellingsen EB, O'Day S, Mezheyeuski A, Gromadka A, et al. Clin Cancer Res 2023 Jun 28:CCR-23-0416. doi: 10.1158/1078-0432.CCR-23-0416.

Read + Share

Amedeo Smart

Independent Medical Education

Ellingsen EB, O'Day S, Mezheyeuski A, Gromadka A, et al. Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial. Clin Cancer Res 2023 Jun 28:CCR-23-0416. doi: 10.1158/1078-0432.CCR-23-0416.
PMID: 37378632